Interventional Study on the Impact of the Hypnosis Used as Sedation or Relaxation in the Breast Oncologic Surgery
NCT ID: NCT03330717
Last Updated: 2021-06-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
284 participants
INTERVENTIONAL
2017-11-15
2019-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Comparaison of pain ( different types of pain), consumption of pain killers ,anxiety and fatigue on day0,1, 8 after surgery and every. 3 months during the first 2 years of follow up.
Comparisons are also performed in substudies defined by treatments modalités. Inflammatory parameters s ( CRP\_ C reactive protein, NLR- ( neutrophils to lymphocyte ratio) are measured on Day 0, 1, 8 and also salivary Immunoglobulins and different endocannabinoids.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Using Hypnosis and Virtual Reality During Pre and Postoperative Cardiovascular Surgery.
NCT03820700
Effects of Virtual Reality Hypnosis on Anxiety, Pain and Comfort in Oncology Patients During a Port-catheter Placement Procedure
NCT06883786
Neurophysiological Correlates of Dissociation Induced by Virtual Reality Hypnosis (VRH) in a Clinical Population
NCT05362708
Virtual Reality (VR) to Reduce Preoperative Anxiety.
NCT03905915
Impact of Virtual Reality Hypnosis Before an Invasive Medical Procedure for Patients With Chronic Pain
NCT06082427
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Our hypothesis was that hypnosis sedation generates less perioperative inflammatory reaction.
A substudy of 50 patients was also dedicated to the investigation ofsalivary immunoglobulins and dosage of differents endocannabinoids
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
General anesthesia
Patients will undergo oncologic breast surgery on general anesthesia.
General anesthesia
Patients will undergo oncologic breast surgery on general anesthesia.
Hypnosis sedation
Patients will undergo oncologic breast surgery on hypnosis sedation.
Hypnosis sedation
Patients will undergo oncologic breast surgery on hypnosis sedation.
General anesthesia with preoperative session of hypnosis
Patients interested in hypnosis but too anxious to have surgery while on hypnosis sedation will undergo surgery on general anesthesia but will have a preoperative session of hypnosis relaxation using technology of virtual reality
General anesthesia with preoperative session of hypnosis
Patients will undergo surgery on general anesthesia but will have a preoperative session of hypnosis relaxation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
General anesthesia
Patients will undergo oncologic breast surgery on general anesthesia.
Hypnosis sedation
Patients will undergo oncologic breast surgery on hypnosis sedation.
General anesthesia with preoperative session of hypnosis
Patients will undergo surgery on general anesthesia but will have a preoperative session of hypnosis relaxation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Signed informed consent form
* Patient has to be in possession of her administrative laws and affiliated to the social security insurance.
* The patient must have a diagnosis of resectable breast cancer (in situ or invasive breast cancer). . Surgical procedure must include evaluation of the axillary area (sentinel lymph node biopsy and or axillary dissection)
Exclusion Criteria
* No signed informed consent form
* Patients who haven't her social security insurance and prisoners are not eligible.
* No evaluation of the axillary area.
* Breast cancer in men
18 Years
100 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Martine Berlière, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital de Jolimont
Haine-Saint-Paul, Hainaut, Belgium
Cliniques Universitaires Saint-Luc
Brussels, , Belgium
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016/08JUL/311
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.